Latest Insider Transactions at Medpace Holdings, Inc. (MEDP)
This section provides a real-time view of insider transactions for Medpace Holdings, Inc. (MEDP). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Medpace Holdings, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Medpace Holdings, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 17
2023
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
50,000
-0.86%
|
$13,650,000
$273.91 P/Share
|
|
Nov 17
2023
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
50,000
-0.86%
|
$13,650,000
$273.91 P/Share
|
|
Nov 16
2023
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
17,000
-0.29%
|
$4,777,000
$281.61 P/Share
|
|
Nov 16
2023
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
17,000
-0.29%
|
$4,777,000
$281.61 P/Share
|
|
Nov 15
2023
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
33,000
-0.56%
|
$9,339,000
$283.42 P/Share
|
|
Nov 15
2023
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
33,000
-0.56%
|
$9,339,000
$283.42 P/Share
|
|
Nov 14
2023
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
25,000
-0.42%
|
$7,075,000
$283.11 P/Share
|
|
Nov 14
2023
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
25,000
-0.42%
|
$7,075,000
$283.11 P/Share
|
|
Oct 23
2023
|
Susan E Burwig Exec. VP, Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+21.32%
|
$240,000
$32.05 P/Share
|
|
Sep 30
2023
|
Cornelius P. Mc Carthy Iii Director |
BUY
Exercise of conversion of derivative security
|
Direct |
82
+25.0%
|
-
|
|
Sep 30
2023
|
Robert O. Kraft Director |
BUY
Exercise of conversion of derivative security
|
Direct |
94
+25.0%
|
-
|
|
Sep 30
2023
|
Brian T Carley Director |
BUY
Exercise of conversion of derivative security
|
Direct |
103
+1.32%
|
-
|
|
Sep 21
2023
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
61,655
-1.03%
|
$15,043,820
$244.27 P/Share
|
|
Sep 21
2023
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
61,655
-1.03%
|
$15,043,820
$244.27 P/Share
|
|
Sep 20
2023
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
65,653
-1.09%
|
$16,741,515
$255.48 P/Share
|
|
Sep 20
2023
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
65,653
-1.09%
|
$16,741,515
$255.48 P/Share
|
|
Sep 19
2023
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
137,379
-2.22%
|
$35,581,161
$259.66 P/Share
|
|
Sep 19
2023
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
137,379
-2.22%
|
$35,581,161
$259.66 P/Share
|
|
Sep 18
2023
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
53,385
-0.86%
|
$14,627,490
$274.76 P/Share
|
|
Sep 18
2023
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
53,385
-0.86%
|
$14,627,490
$274.76 P/Share
|
|
Aug 14
2023
|
Robert O. Kraft Director |
SELL
Open market or private sale
|
Direct |
13,782
-98.65%
|
$3,652,230
$265.67 P/Share
|
|
Aug 14
2023
|
Robert O. Kraft Director |
BUY
Exercise of conversion of derivative security
|
Direct |
13,782
+49.66%
|
$358,332
$26.44 P/Share
|
|
Jul 31
2023
|
Kevin M. Brady CFO & Treasurer |
SELL
Open market or private sale
|
Direct |
7,000
-53.85%
|
$1,785,000
$255.0 P/Share
|
|
Jul 31
2023
|
Kevin M. Brady CFO & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+43.48%
|
$900,000
$90.65 P/Share
|
|
Jul 27
2023
|
Stephen P Ewald General Counsel & Corp. Secy. |
SELL
Open market or private sale
|
Direct |
21,850
-59.53%
|
$5,549,900
$254.39 P/Share
|
|
Jul 27
2023
|
Stephen P Ewald General Counsel & Corp. Secy. |
BUY
Exercise of conversion of derivative security
|
Direct |
21,850
+37.32%
|
$2,337,950
$107.93 P/Share
|
|
Jun 30
2023
|
Brian T Carley Director |
BUY
Exercise of conversion of derivative security
|
Direct |
103
+1.34%
|
-
|
|
Jun 30
2023
|
Cornelius P. Mc Carthy Iii Director |
BUY
Exercise of conversion of derivative security
|
Direct |
82
+33.33%
|
-
|
|
Jun 30
2023
|
Robert O. Kraft Director |
BUY
Exercise of conversion of derivative security
|
Direct |
94
+33.33%
|
-
|
|
Jun 15
2023
|
Brian T Carley Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,400
+49.65%
|
$170,200
$23.0 P/Share
|
|
Jun 08
2023
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
49,347
-0.79%
|
$10,856,340
$220.85 P/Share
|
|
Jun 08
2023
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
49,347
-0.79%
|
$10,856,340
$220.85 P/Share
|
|
Jun 07
2023
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
110,324
-1.73%
|
$24,602,252
$223.05 P/Share
|
|
Jun 07
2023
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
110,324
-1.73%
|
$24,602,252
$223.05 P/Share
|
|
Jun 06
2023
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
58,681
-0.91%
|
$12,909,820
$220.46 P/Share
|
|
Jun 06
2023
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
58,681
-0.91%
|
$12,909,820
$220.46 P/Share
|
|
Apr 25
2023
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
31,648
-0.49%
|
$6,994,208
$221.83 P/Share
|
|
Apr 25
2023
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
31,648
-0.49%
|
$6,994,208
$221.83 P/Share
|
|
Mar 31
2023
|
Brian T Carley Director |
BUY
Exercise of conversion of derivative security
|
Direct |
104
+50.0%
|
-
|
|
Mar 31
2023
|
Cornelius P. Mc Carthy Iii Director |
BUY
Exercise of conversion of derivative security
|
Direct |
82
+50.0%
|
-
|
|
Mar 31
2023
|
Robert O. Kraft Director |
BUY
Exercise of conversion of derivative security
|
Direct |
94
+50.0%
|
-
|
|
Nov 16
2022
|
Kevin M. Brady CFO & Treasurer |
SELL
Open market or private sale
|
Direct |
344
-10.29%
|
$78,088
$227.09 P/Share
|
|
Nov 15
2022
|
Jesse J Geiger President |
SELL
Open market or private sale
|
Direct |
7,000
-52.31%
|
$1,610,000
$230.0 P/Share
|
|
Nov 15
2022
|
Jesse J Geiger President |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+34.34%
|
$196,000
$28.32 P/Share
|
|
Nov 15
2022
|
Kevin M. Brady CFO & Treasurer |
SELL
Open market or private sale
|
Direct |
1,656
-33.12%
|
$379,224
$229.3 P/Share
|
|
Nov 01
2022
|
Robert O. Kraft Director |
SELL
Open market or private sale
|
Direct |
9,630
-100.0%
|
$2,128,230
$221.42 P/Share
|
|
Nov 01
2022
|
Robert O. Kraft Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,630
+50.0%
|
$221,490
$23.0 P/Share
|
|
Oct 27
2022
|
Stephen P Ewald General Counsel & Corp. Secy. |
SELL
Open market or private sale
|
Direct |
6,500
-30.44%
|
$1,430,000
$220.53 P/Share
|
|
Oct 27
2022
|
Stephen P Ewald General Counsel & Corp. Secy. |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+23.34%
|
$208,000
$32.05 P/Share
|
|
Sep 22
2022
|
Medpace Investors, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
57,426
+0.88%
|
$8,843,604
$154.59 P/Share
|